0 CHECKOUT

Dollar General Corp. Aug 11

  • ID: 1869494
  • August 2011
  • Standard & Poors

Abstract
Good market position in 'extreme-value' retail segment Good operating performance due to management initiatives and consumers trading down Intensely competitive industry Aggressive growth plans The ratings on Dollar General reflect our expectation that the company's value-focused merchandising strategy and continued store expansion will sustain the positive operating momentum and contribute to further improvement in credit measures. We view Dollar General's business risk as satisfactory, based on its good market position as the largest dollar-store chain in the U.S., with over 9,000 stores and good prospects for future growth, as well as improved merchandising and operating efficiencies. Given the company's extreme value proposition and the currently weak economy, we believe Dollar General has benefited from consumers trading down. In addition, restructuring...

Companies mentioned in this report are: Dollar General Corp.
Action: Review

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown

Dollar General Corp.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This Credit Rating Report will be emailed to you.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.